Literature DB >> 30454825

Histopathology of Alcohol-Related Liver Diseases.

Nitzan C Roth1, Jia Qin2.   

Abstract

Excessive alcohol consumption can lead to a spectrum of liver histopathology, including steatosis, steatohepatitis, foamy degeneration, fatty liver with cholestasis, and cirrhosis. Although variability in sampling and pathologist interpretation are of some concern, liver biopsy remains the gold standard for distinguishing between steatohepatitis and noninflammatory histologic patterns of injury that can also cause the clinical syndrome of alcohol-related hepatitis. Liver biopsy is not routinely recommended to ascertain a diagnosis of alcohol-related liver disease in patients with an uncertain alcohol history, because the histologic features of alcohol-related liver diseases can be found in other diseases, including nonalcoholic steatohepatitis and drug-induced liver injury.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alcohol-related liver disease; Alcoholic fatty liver with cholestasis; Alcoholic foamy degeneration; Alcoholic hepatitis; Alcoholic steatohepatitis; Histology; Liver biopsy

Mesh:

Year:  2019        PMID: 30454825     DOI: 10.1016/j.cld.2018.09.001

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  5 in total

Review 1.  Mechanisms, biomarkers and targets for therapy in alcohol-associated liver injury: From Genetics to nutrition: Summary of the ISBRA 2018 symposium.

Authors:  Irina A Kirpich; Dennis R Warner; Wenke Feng; Swati Joshi-Barve; Craig J McClain; Devanshi Seth; Wei Zhong; Zhanxiang Zhou; Natalia A Osna; Kusum K Kharbanda
Journal:  Alcohol       Date:  2019-05-23       Impact factor: 2.405

2.  Liver metabolomics identifies bile acid profile changes at early stages of alcoholic liver disease in mice.

Authors:  Georgia Charkoftaki; Wan Ying Tan; Pablo Berrios-Carcamo; David J Orlicky; Jaya Prakash Golla; Rolando Garcia-Milian; Reza Aalizadeh; Nikolaos S Thomaidis; David C Thompson; Vasilis Vasiliou
Journal:  Chem Biol Interact       Date:  2022-04-14       Impact factor: 5.168

3.  Efficacy of Thiamine and Medical Management in Treating Hyperuricemia in AUD Patients with ALD: Role of Hyperuricemia in Liver Injury, Gut-Barrier Dysfunction, and Inflammation.

Authors:  Vatsalya Vatsalya; Fengyuan Li; Jane Frimodig; Nihar Shah; Amar Sutrawe; Wenke Feng
Journal:  Clin Exp Pharmacol       Date:  2021-07-28

4.  Alcohol-Related Liver Disease in the Covid-19 Era: Position Paper of the Italian Society on Alcohol (SIA).

Authors:  Gianni Testino; Teo Vignoli; Valentino Patussi; Pierluigi Allosio; Maria Francesca Amendola; Sarino Aricò; Aniello Baselice; Patrizia Balbinot; Vito Campanile; Tiziana Fanucchi; Giovanni Greco; Livia Macciò; Cristina Meneguzzi; Davide Mioni; Vincenzo Ostilio Palmieri; Michele Parisi; Doda Renzetti; Raffaella Rossin; Claudia Gandin; Luigi Carlo Bottaro; Mauro Bernardi; Giovanni Addolorato; Lisa Lungaro; Giorgio Zoli; Emanuele Scafato; Fabio Caputo
Journal:  Dig Dis Sci       Date:  2021-06-17       Impact factor: 3.487

5.  Mechanism of Paeoniflorin in the Treatment of Bile Duct Ligation-Induced Cholestatic Liver Injury Using Integrated Metabolomics and Network Pharmacology.

Authors:  Shizhang Wei; Xiao Ma; Ming Niu; Ruilin Wang; Tao Yang; Dan Wang; Jianxia Wen; Haotian Li; Yanling Zhao
Journal:  Front Pharmacol       Date:  2020-10-20       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.